Literature DB >> 9238350

The sequelae of childhood sexual abuse: a primary care focus for adult female survivors.

S J Roberts1.   

Abstract

Researchers have increasingly demonstrated that 15% to 30% of all women have been sexually abused as children. Information on the emotional, behavioral, and cognitive sequelae of this abuse has been available. Most recently, a literature on the somatic and medical sequelae has developed. This article reviews this literature and discusses its implications for primary care providers. Survivors are likely to suffer from insomnia, gastrointestinal problems, obesity, chronic pain, headache, and somatization, and they are frequent utilizers of primary care services. Specific suggestions about history taking, physical examination, and referrals are given to ensure that survivors receive care that is sensitive, supportive, and competent. The article also discusses the dynamics of abuse and how they relate to the ongoing relationship between the primary care provider and the survivor of sexual abuse.

Entities:  

Mesh:

Year:  1996        PMID: 9238350     DOI: 10.1097/00006205-199621120-00004

Source DB:  PubMed          Journal:  Nurse Pract        ISSN: 0361-1817


  4 in total

1.  Obesity and sexual abuse in American Indians and Alaska Natives.

Authors:  James A Levine; Shelly K McCrady-Spitzer; William Bighorse
Journal:  J Obes Weight Loss Ther       Date:  2016-08-29

2.  Sexual assault among North Carolina women: prevalence and health risk factors.

Authors:  S Cloutier; Sandra L Martin; C Poole
Journal:  J Epidemiol Community Health       Date:  2002-04       Impact factor: 3.710

Review 3.  Screening children for family violence: a review of the evidence for the US Preventive Services Task Force.

Authors:  Peggy Nygren; Heidi D Nelson; Jonathan Klein
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

4.  Effect of childhood trauma on disease severity in patients with fibromyalgia: The mediating role of psychological resilience.

Authors:  Özlem Kazan Kızılkurt; Arda Kazım Demirkan; Ferzan Ergün Gıynaş; Hüseyin Güleç
Journal:  Arch Rheumatol       Date:  2021-06-24       Impact factor: 1.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.